Focused radiation after surgery for certain meningiomas
Part of Brain & nervous system, Cancer clinical trials.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of a grade 2 meningioma (newly diagnosed) or a recurring grade 1 meningioma.
- You must have had a complete surgical removal of the meningioma (as deemed by your neurosurgeon).
- You must not have had radiation therapy to the brain that overlaps with the area to be treated in this study.
- You must not be pregnant (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different radiation methods for treating a slow-growing, non-cancerous brain tumor at the base of the skull. It aims to see which approach best protects memory and thinking abilities.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This study looks at whether adding radiation therapy right after surgery is better than waiting and watching for certain meningiomas. It also checks if just watching is safe for people with lower-risk tumors.
This study tests a type of radiation called stereotactic radiosurgery (SRS) given right after surgery to remove a brain tumor. The goal is to see if it helps control the tumor with fewer side effects.
This study looks at people with a small number of brain metastases who are treated with a focused, staged form of radiation after surgery or to treat the cancer. It may help doctors better understand how well this approach works and who benefits most.
This study tests whether giving radiation therapy after surgery helps prevent atypical meningioma from coming back. It is for people who had the tumor completely removed and are between 18 and 70 years old.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.